You walk into a pharmacy and see a retinol serum for $40. You check your telehealth provider's site and see tretinoin cream for roughly the same price — but it requires a medical consultation. Why the difference? What makes one ingredient a drug and the other a cosmetic? And does it actually matter for your skin?

The answer comes down to regulation, concentration, and a body of clinical research that took decades to build. This guide breaks down how prescription skincare works, which ingredients cross from OTC into prescription territory, and how to think about the tradeoff.

What Makes a Skincare Product a Prescription Drug?

The short answer: The FDA classifies a product as a drug — not a cosmetic — when it is intended to affect the structure or function of the body, or to diagnose, mitigate, treat, cure, or prevent disease. If a skincare product crosses that line, it requires either FDA approval or a valid prescription. Cosmetics, by contrast, are legally limited to altering appearance without changing underlying biology.

The legal dividing line between a cosmetic and a drug is the product's intended use, not its ingredients alone. The FDA's guidance on this is explicit: "A product can be both a cosmetic and a drug. This may happen when a product has two intended uses."1

Sunscreen is a well-known example — it both beautifies (cosmetic) and prevents sunburn damage (drug). Prescription tretinoin goes further: its intended use is expressly therapeutic, which is why it cannot be sold over the counter in standard formulations in the United States.

The 2022 Modernization of Cosmetics Regulation Act (MoCRA) updated oversight requirements for the cosmetics industry significantly, but it did not change this fundamental line. Prescription drugs still require a licensed provider to prescribe them.1

The Retinoid Spectrum: OTC Retinol vs. Prescription Tretinoin

The short answer: Retinol and tretinoin are both forms of vitamin A, but they are not the same molecule. Tretinoin (all-trans retinoic acid) is the active form that binds directly to retinoic acid receptors in skin cells. Retinol requires two conversion steps in the skin before it becomes active. That conversion gap means the two ingredients differ meaningfully in potency — and in regulatory status.

Retinol is available over the counter in concentrations typically ranging from 0.025% to 1.0%. It does not require a prescription because, at those concentrations and with its cosmetic intended use, it is classified as a cosmetic ingredient. Tretinoin, on the other hand, has been FDA-approved as a prescription drug since 1971 — first for acne, and later for the mitigation of certain photoaging changes in patients following comprehensive skincare programs.2

The research on tretinoin's mechanism is substantial. A landmark 1993 study published in the New England Journal of Medicine found that treatment of photodamaged skin with tretinoin produced an 80 percent increase in type I collagen formation in the papillary dermis, compared to a 14 percent decrease with vehicle alone.2 That study, authored by Griffiths, Russman, Majmudar, and colleagues, helped establish the cellular basis for what clinicians observe in practice.

A 2009 review in PMC summarizing clinical evidence for retinoids in skin aging found that prescription-strength retinoids show consistent histological changes — including new collagen deposition, epidermal thickening, and normalization of melanocytes — that are documented across multiple randomized controlled trials.3 The same review noted that OTC retinol, while potentially useful, shows "approximately 20-fold lower potency" than tretinoin when matched by weight, and that evidence for OTC retinol remains weaker by the standards of controlled clinical research.

A 2021 systematic review of OTC vitamin A cosmetic products concluded that while some retinol products produced "mild ameliorating effects" on photoaging, only five of nine reviewed RCTs reported statistically significant results, and the evidence was generally described as weak to moderate.4

The practical takeaway: prescription tretinoin has a longer and stronger evidence base than OTC retinol. That does not mean retinol is useless — but it does explain why the two are regulated differently and priced differently.

Which Other Skincare Ingredients Require a Prescription?

The short answer: Beyond tretinoin, several common skincare actives cross into prescription territory based on concentration, mechanism, or intended use. Hydroquinone at 4% concentration is prescription-only in the U.S. Azelaic acid is available both OTC (up to 10%) and by prescription (15–20%). Certain topical antibiotics, clindamycin for acne, and combination formulas with multiple actives also typically require a prescription.

Here is a practical breakdown of where key ingredients fall:

Tretinoin (all-trans retinoic acid)

Hydroquinone

Azelaic acid

Topical antibiotics (clindamycin, erythromycin)

Spironolactone (oral, for hormonal acne)

The pattern across all of these: prescription status follows either the drug's mechanism (it changes how the body works, not just how it looks) or a concentration threshold where safety monitoring becomes clinically appropriate.

Why Concentration and Delivery Matter As Much As the Ingredient

The short answer: The same molecule can be a cosmetic at one concentration and a drug at another. This is not a marketing distinction — it reflects genuine differences in biological activity, absorption, and the type of medical oversight that becomes appropriate.

This is most visible with hydroquinone: 2% was sold OTC for decades, while 4% has always required a prescription. The same logic applies to retinoids. A 0.3% retinol serum from a beauty brand operates under cosmetics regulations and requires no safety testing for efficacy claims. Tretinoin 0.05% is a New Drug Application product with clinical trial data behind it.

Formulation also matters. Prescription tretinoin is often compounded to specific concentrations or combined with complementary actives — niacinamide to support tolerability, for example — in ways that OTC products cannot legally replicate under cosmetics rules. Compounded formulations made by licensed 503A pharmacies are customized to a patient's specific clinical profile. That customization is part of what the prescription pathway enables.

This is also why the term "medical-grade skincare" is worth scrutinizing. Some brands use it to imply clinical rigor for products that are, legally, just cosmetics with higher-quality manufacturing standards. Prescription-only formulations are held to a different legal and evidentiary standard than cosmetics, regardless of the marketing language around them.

When Is Prescription Skincare Worth Pursuing?

The short answer: Prescription skincare makes the most sense when the condition is driven by a mechanism that requires biological intervention — acne driven by follicular hyperkeratinization, melasma from chronic melanocyte overactivity, or photodamage that involves structural changes in the dermis. OTC options may support skin health and appearance, but they operate within cosmetic limits.

A few scenarios where a prescription consultation typically makes sense:

Prescription skincare does not replace a comprehensive routine. Sunscreen, gentle cleansing, and hydration remain the foundation. Prescription actives work within that foundation — they are not a shortcut around it.

Ready to get started?

Take our free assessment and get matched with a physician-directed protocol.

Take the Free Assessment →

The Telehealth Option: Prescription Skincare Without the Wait

The short answer: Licensed telehealth providers can prescribe skincare medications after a clinical intake — typically a short online questionnaire and an asynchronous provider review. This is how most people access prescription tretinoin and compounded formulations today, without an in-person dermatology appointment.

The model works because prescription skincare for common conditions — acne, photodamage, melasma — is well-studied and does not require physical examination in most cases. A provider reviews your intake, photographs if required, and medical history; writes a prescription if clinically appropriate; and the medication ships from a licensed pharmacy.

Prescription skincare is available through Nuvari's Glow Protocol, which includes a provider consultation and pharmacy-compounded formulations shipped to your door.

What to Expect When Starting Prescription Skincare

Starting prescription retinoids — tretinoin, specifically — involves an adjustment period that is worth understanding before you begin.

The first 4–6 weeks often involve some degree of dryness, flaking, or mild redness. This is commonly called "retinization" and reflects the skin's adjustment to accelerated cell turnover. It is not a sign the product is working too aggressively — it is usually a signal to adjust application frequency or concentration, which is something your provider can guide you through.

Clinically, most published research on tretinoin evaluates outcomes at 12–24 weeks. A 1994 PubMed study examining histologic improvement in photodamage found measurable dermal changes after 12 months of low-concentration tretinoin use.3 Results are not immediate, and nobody who tells you otherwise is working from the evidence.

Practical steps for starting:

  1. Begin with the lowest appropriate concentration (typically 0.025% or 0.05% cream)
  2. Apply to dry skin, 20–30 minutes after cleansing
  3. Start 2–3 nights per week; increase frequency as tolerated over 4–8 weeks
  4. Use a broad-spectrum SPF 30+ every morning without exception — tretinoin increases UV sensitivity
  5. Check in with your provider at the 8–12 week mark to assess progress and adjust if needed

Frequently Asked Questions

Can I use tretinoin while pregnant or breastfeeding?

No. Prescription retinoids are contraindicated in pregnancy due to the known teratogenic risk of oral retinoids; topical tretinoin carries a Category C / Category D designation depending on formulation. Always disclose pregnancy status or plans during your provider intake. This is one reason a clinical consultation matters — not just a product purchase.

Is OTC retinol ever good enough?

For some people, yes. Research suggests OTC retinol can produce modest improvements in skin texture and evenness over time, though the evidence base is significantly thinner than for prescription tretinoin.4 If your goals are mild and your skin is sensitive, OTC retinol is a reasonable starting point. If you've been using retinol consistently for 3–6 months without meaningful change, a prescription option is worth discussing with a provider.

Why does prescription tretinoin require a consultation if it's been around since the 1970s?

Because even well-studied drugs can interact with other medications, be contraindicated in certain health contexts, or be appropriate at different concentrations depending on individual factors. A provider review is not bureaucracy — it is the mechanism that makes prescribing safe.

How is compounded tretinoin different from brand-name products?

Compounded tretinoin is prepared by a licensed 503A pharmacy for a specific patient's prescription. This allows for custom concentrations, delivery vehicles (cream vs. gel vs. serum base), and combination with other actives. Brand-name products like Retin-A are FDA-approved at fixed concentrations. Both require a prescription.

Does insurance cover prescription skincare?

It depends on the indication. Tretinoin prescribed for acne is often covered; when prescribed for photoaging, it is frequently not. Telehealth-based prescription services typically operate outside insurance networks with transparent cash pricing.

Sources

  1. U.S. Food and Drug Administration. "Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)" FDA.gov. https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap
  2. Griffiths CE, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. "Restoration of Collagen Formation in Photodamaged Human Skin by Tretinoin (Retinoic Acid)." New England Journal of Medicine. 1993;329(8):530–535. https://www.nejm.org/doi/full/10.1056/NEJM199308193290803
  3. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. "Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety." Clinical Interventions in Aging. 2006;1(4):327–348. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699641/
  4. Zasada M, Budzisz E. "Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review." Journal of Clinical and Aesthetic Dermatology. 2021. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC8675340/
  5. Arowojolu OA, Charrow A. "Post-hydroquinone era: Decoding shifting trends in skin-lightening ingredient searches." PMC. 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626305/